miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study

miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study

microRNAs (miRNAs) have been proposed as promising molecular biomarkers for diagnosis, prognosis, and responsive therapeutic targets in different types of cancer, including colorectal cancer (CRC). In this study, we evaluated the expression levels of 84 cancer-associated miRNAs in a cohort of 39 hum...

Full description

Bibliographic Details
Main Authors:	Elena Milanesi, Maria Dobre, Alina Ioana Bucuroiu, Vlad Herlea, Teodora Ecaterina Manuc, Alessandro Salvi, Giuseppina De Petro, Mircea Manuc, Gabriel Becheanu
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2020/4927120

Similar Items

Differential Intestinal Mucosa Transcriptomic Biomarkers for Crohn’s Disease and Ulcerative Colitis
by: Maria Dobre, et al.
Published: (2018-01-01)

Dysregulation of miRNAs Targeting the IGF-1R Pathway in Pancreatic Ductal Adenocarcinoma
by: Maria Dobre, et al.
Published: (2021-07-01)

Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targets
by: Manuc TE, et al.
Published: (2016-03-01)

Crosstalk Between DNA Methylation and Gene Mutations in Colorectal Cancer
by: Maria Dobre, et al.
Published: (2021-07-01)

Impact of cellular miRNAs on circulating miRNA biomarker signatures.
by: Radha Duttagupta, et al.
Published: (2011-01-01)

MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma
by: Babak Otoukesh, et al.
Published: (2020-06-01)

Signature miRNAs involved in the innate immunity of invertebrates.
by: Geng Yang, et al.
Published: (2012-01-01)

Facebook self-(re)presentation and the employers’ practice of using it as a recruitment tool
by: Elena - Mădălina VĂTĂMĂNESCU, et al.
Published: (2013-09-01)

An Integrated Analysis of mRNAs and miRNAs Microarray Profiles to Screen miRNA Signatures Involved in Nasopharyngeal Carcinoma
by: Lei Liu MD, et al.
Published: (2020-09-01)

A 2 miRNAs-based signature for the diagnosis of atherosclerosis
by: Xiujiang Han, et al.
Published: (2021-03-01)

Somatostatinoma and Neurofibromatosis Type 1-A Case Report and Review of the Literature
by: Sorina Martin, et al.
Published: (2020-08-01)

KRAS-dependent sorting of miRNA to exosomes
by: Diana J Cha, et al.
Published: (2015-07-01)

Cytokine Targeting by miRNAs in Autoimmune Diseases
by: Valentina Salvi, et al.
Published: (2019-01-01)

Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas
by: Elisa Baldelli, et al.
Published: (2021-09-01)

The Tumor Cytosol miRNAs, Fluid miRNAs and Exosome miRNAs in Lung Cancer
by: Xin eQin, et al.
Published: (2015-01-01)

Integrated Analysis of miRNA and mRNA Endorses a Twenty miRNAs Signature for Colorectal Carcinoma
by: Andrea Angius, et al.
Published: (2019-08-01)

Signature miRNAs in peripheral blood monocytes of patients with gastric or breast cancers
by: Le Shu, et al.
Published: (2018-10-01)

Identification of exosomes and its signature miRNAs of male and female Cynoglossus semilaevis
by: Zhanpeng Sun, et al.
Published: (2017-04-01)

In silico analysis of wild-type and mutant KRAS
by: Frengki Frengki, et al.
Published: (2019-05-01)

Identification of wild soybean miRNAs and their target genes responsive to aluminum stress
by: Zeng Qiao-Ying, et al.
Published: (2012-10-01)

Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene.
by: Miljana Tanic, et al.
Published: (2012-01-01)

KRAS-associated microRNAs in colorectal cancer
by: Hamizah Ibrahim, et al.
Published: (2020-07-01)

Subjective Global Assessment and Handgrip Strength as Predictive Factors in Patients with Liver Cirrhosis
by: Maria Ciocîrlan, et al.
Published: (2017-01-01)

Cold-responsive miRNAs and their target genes in the wild eggplant species Solanum aculeatissimum
by: Xu Yang, et al.
Published: (2017-12-01)

Conserved miRNAs and Their Response to Salt Stress in Wild Eggplant Solanum linnaeanum Roots
by: Yong Zhuang, et al.
Published: (2014-01-01)

KRAS-dependent Regulation of Extracellular RNAs in Colorectal Cancer
by: Cha, Diana Jean
Published: (2017)

KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
by: Shuang-Ni Yu, et al.
Published: (2016-12-01)

Adalimumab versus infliximab in treating post-operative recurrence of Crohn's disease: a national cohort study
by: Carmen-Monica Preda, et al.

Sarcopenia: Etiology, Nutritional Approaches, and miRNAs
by: Roberto Cannataro, et al.
Published: (2021-09-01)

Pancreatogenic type 3C diabetes
by: Anca Pantea-Stoian, et al.
Published: (2018-10-01)

A three miRNAs signature predicts survival in cervical cancer using bioinformatics analysis
by: Bin Liang, et al.
Published: (2017-07-01)

miRNAs expression signature potentially associated with lymphatic dissemination in locally advanced prostate cancer
by: Elena A. Pudova, et al.
Published: (2020-09-01)

Glioblastoma and MiRNAs
by: Swalih P. Ahmed, et al.
Published: (2021-03-01)

Use of miRNAs as Biomarkers in Sepsis
by: Raluca Dumache, et al.
Published: (2015-01-01)

KRAS regulation by small non-coding RNAs and SNARE proteins
by: Yonglu Che, et al.
Published: (2019-11-01)

Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients.
by: Yu-Lin Lin, et al.
Published: (2014-01-01)

Identification of a Novel Metastasis-Related miRNAs-Based Signature for Predicting the Prognosis of Hepatocellular Carcinoma
by: Yuan Chen, et al.
Published: (2021-01-01)

Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases
by: Masaru eKatoh
Published: (2014-10-01)

MiRNAs in kidney disease
by: Papadopoulos, Theofilos
Published: (2016)

Genes, Cells, and miRNAs
by: Edit Gara, et al.
Published: (2019-01-01)